tiprankstipranks
Advertisement
Advertisement
Sophia Genetics raises FY26 revenue view to $94M-$96M from $92M-$94M
PremiumThe FlySophia Genetics raises FY26 revenue view to $94M-$96M from $92M-$94M
1M ago
SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing
Premium
Company Announcements
SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing
1M ago
Analyst Reiterates Buy on SOPHiA GENETICS, Sees Accelerating Growth and Attractive Valuation with Unchanged $12 Price Target
Premium
Ratings
Analyst Reiterates Buy on SOPHiA GENETICS, Sees Accelerating Growth and Attractive Valuation with Unchanged $12 Price Target
1M ago
Sophia Genetics $40M Spot Secondary re-offered at $4.75
PremiumThe FlySophia Genetics $40M Spot Secondary re-offered at $4.75
3M ago
Sophia Genetics announces ordinary share offering, no amount given
Premium
The Fly
Sophia Genetics announces ordinary share offering, no amount given
3M ago
Sophia Genetics appoints Ross Muken as CEO
Premium
The Fly
Sophia Genetics appoints Ross Muken as CEO
3M ago
Sophia Genetics, Synnovis team on liquid biopsy testing for UK cancer patients
PremiumThe FlySophia Genetics, Synnovis team on liquid biopsy testing for UK cancer patients
4M ago
SOPHiA GENETICS Calls 2026 AGM as It Highlights Breakout 2025 Growth
Premium
Company Announcements
SOPHiA GENETICS Calls 2026 AGM as It Highlights Breakout 2025 Growth
4M ago
SOPHiA GENETICS Earnings Call: Growth With Caveats
Premium
Company Announcements
SOPHiA GENETICS Earnings Call: Growth With Caveats
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100